Advertisement

Gish Biomedical Inc.: The Irvine manufacturer of...

Share

Gish Biomedical Inc.: The Irvine manufacturer of surgical products said Monday that it has received Federal Food and Drug Administration approval to market MyoManager, its latest product to control the heart during open heart surgery. The company plans full market release of the MyoManager in November.

Advertisement